Works matching IS 02683369 AND DT 2007 AND VI 40 AND IP 2

Results: 14

Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 111, doi. 10.1038/sj.bmt.1705708
By:
- Tomblyn, M.;
- Burns, L. J.;
- Blazar, B.;
- Wagner, J.;
- Lee, C.;
- Rogers, T.;
- McGlave, P.;
- Miller, J. S.;
- Weisdorf, D. J.
Publication type:
Article
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 93, doi. 10.1038/sj.bmt.1705667
By:
- Kennedy-Nasser, A. A.;
- Bollard, C. M.
Publication type:
Article
Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 105, doi. 10.1038/sj.bmt.1705685
By:
- Iravani, M.;
- Evazi, M. R.;
- Mousavi, S. A.;
- Shamshiri, A. R.;
- Tavakoli, M.;
- Ashouri, A.;
- Samiee, S.;
- Chahardovali, B.;
- Alimoghaddam, K.;
- Ghaffari, S. H.;
- Ghavamzadeh, A.
Publication type:
Article
The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 165, doi. 10.1038/sj.bmt.1705689
By:
- Torikai, H.;
- Akatsuka, Y.;
- Miyauchi, H.;
- Terakura, S.;
- Onizuka, M.;
- Tsujimura, K.;
- Miyamura, K.;
- Morishima, Y.;
- Kodera, Y.;
- Kuzushima, K.;
- Takahashi, T.
Publication type:
Article
Central nervous system graft-versus-host disease presenting with granulomatous encephalitis.
Published in:
2007
By:
- Kew, A. K.;
- Macaulay, R.;
- Burrell, S.;
- Rubin, S.;
- Dow, G.;
- Couban, S.
Publication type:
Letter
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 157, doi. 10.1038/sj.bmt.1705686
By:
- Slavin, M. A.;
- Grigg, A. P.;
- Schwarer, A. P.;
- Szer, J.;
- Spencer, A.;
- Sainani, A.;
- Thursky, K. A.;
- Roberts, A. W.
Publication type:
Article
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 125, doi. 10.1038/sj.bmt.1705699
By:
- Özdemir, E.;
- Saliba, R. M.;
- Champlin, R. E.;
- Couriel, D. R.;
- Giralt, S. A.;
- de Lima, M.;
- Khouri, I. F.;
- Hosing, C.;
- Kornblau, S. M.;
- Anderlini, P.;
- Shpall, E. J.;
- Qazilbash, M. H.;
- Molldrem, J. J.;
- Chemaly, R. F.;
- Komanduri, K. V.
Publication type:
Article
Outpatient allografting using non-myeloablative conditioning: the Mexican experience.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 119, doi. 10.1038/sj.bmt.1705700
By:
- Cantú-Rodríguez, O. G.;
- Jaime-Pérez, J. C.;
- Gutiérrez-Aguirre, C. H.;
- González-Llano, O.;
- Mancías-Guerra, C.;
- Tarín-Arzaga, L. C.;
- Ruiz-Delgado, G. J.;
- Sandoval-Villa, C. C.;
- Marfil-Rivera, J.;
- Morales-Toquero, A.;
- Ruiz-Argüelles, G. J.;
- G.ómez-Almaguer, D.
Publication type:
Article
Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 137, doi. 10.1038/sj.bmt.1705701
By:
- Kalpoe, J. S.;
- van der Heiden, P. L. J.;
- Vaessen, N.;
- Claas, E. C. J.;
- Barge, R. M.;
- Kroes, A. C. M.
Publication type:
Article
Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 151, doi. 10.1038/sj.bmt.1705704
By:
- Cadena, J.;
- Taboada, C. A.;
- Burgess, D. S.;
- Ma, J. Z.;
- Lewis, J. S.;
- Freytes, C. O.;
- Patterson, J. E.
Publication type:
Article
The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 2, p. 145, doi. 10.1038/sj.bmt.1705703
By:
- Bogunia-Kubik, K.;
- Jaskula, E.;
- Lange, A.
Publication type:
Article
Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation.
Published in:
2007
By:
- Meniane, J.-C.;
- El-Cheikh, J.;
- Faucher, C.;
- Fürst, S.;
- Bouabdallah, R.;
- Blaise, D.;
- Mohty, M.
Publication type:
Letter
Chimerism does not predict for outcome after alemtuzumab based conditioning.
Published in:
2007
By:
- Michaelis, L.;
- Lin, S.;
- Joseph, L.;
- Artz, A. S.;
- Kline, J.;
- Pollyea, D.;
- Stock, W.;
- Rich, E.;
- Collins-Jones, D.;
- Casey, B.;
- Cerro, P. Del;
- van Besien, K.
Publication type:
Letter
Relevance of drug allergy history after allogeneic hemopoietic stem cell transplantation.
Published in:
2007
By:
- Au, W. Y.
Publication type:
Letter

Works matching IS 02683369 AND DT 2007 AND VI 40 AND IP 2

Difficult stem cell mobilization despite adequate CD34<sup>+</sup> cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma.

T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?

Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.

The HLA-A<sup></sup>0201-restricted minor histocompatibility antigen HA-1<sup>H</sup> peptide can also be presented by another HLA-A2 subtype, A<sup></sup>0206.

Central nervous system graft-versus-host disease presenting with granulomatous encephalitis.

A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.

Outpatient allografting using non-myeloablative conditioning: the Mexican experience.

Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.

Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit.

The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation.

Long-term graft-versus-Waldenström macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation.

Chimerism does not predict for outcome after alemtuzumab based conditioning.

Relevance of drug allergy history after allogeneic hemopoietic stem cell transplantation.